Evidence map›Paper›PMID 34138852›Full record

ArticlePloS one2021

Multispectral co-occurrence of wavelet coefficients for malignancy assessment of brain tumors.

Shaswati Roy, Pradipta Maji

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shaswati RoyDepartment of Information Technology, RCC Institute of Information Technology, Kolkata, West Bengal, India.ORCID 0000-0002-0326-0049
Pradipta MajiBiomedical Imaging and Bioinformatics Lab, Machine Intelligence Unit, Indian Statistical Institute, Kolkata, West Bengal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumor is not most common, but truculent type of cancer. Therefore, correct prediction of its aggressiveness nature at an early stage would influence the treatment strategy. Although several diagnostic methods based on different modalities exist, a pre-operative method for determining tumor malignancy state still remains as an active research area. In this regard, the paper presents a new method for the assessment of tumor grades using conventional MR sequences namely, T1, T1 with contrast enhancement, T2 and FLAIR. The proposed method for tumor gradation is mainly based on feature extraction using multiresolution image analysis and classification using support vector machine. Since the wavelet features of different tumor subregions, obtained from single MR sequence, do not carry equally important information, a wavelet fusion technique is proposed based on the texture information content of each voxel. The concept of texture gradient, used in the proposed algorithm, fuses the wavelet coefficients of the given MR sequences. The feature vector is then derived from the co-occurrence of fused wavelet coefficients. As each wavelet subband contains distinct detail information, a novel concept of multispectral co-occurrence of wavelet coefficients is introduced to capture the spatial correlation among different subbands. It enables to convey more informative features to characterize the tumor type. The effectiveness of the proposed method is analyzed, with respect to six classification performance indices, on BRATS 2012 and BRATS 2014 data sets. The classification accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and area under curve assessed by the ten-fold cross-validation are 91.3%, 96.8%, 66.7%, 92.4%, 88.4%, and 92.0%, respectively, on real brain MR data.

Indexed as

AlgorithmsBrain NeoplasmsMagnetic Resonance ImagingSupport Vector MachineWavelet AnalysisFemaleHumansImage Interpretation, Computer-AssistedMale

Identifiers

PMID34138852
PMCPMC8211259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.